Agios Pharmaceuticals Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Agios Pharmaceuticals Inc with three other
companies in this sector in UNITED STATES :
Travere Therapeutics Inc
sales of $198.32 million
of which 55%
was Tiopronin Products),
Eagle Pharmaceuticals, Inc
of which 100%
was Pharmaceutical), and
of which 63%
During the fourth
quarter of 2020, sales at Agios Pharmaceuticals Inc totalled
an increase of 24.3%
from the $35.44 million in sales at the company during the fourth quarter of 2019.
During the previous 6 quarters, sales at Agios Pharmaceuticals Inc have increased compared with the same quarter in the previous year.
During the year ended December of 2020, sales at
Agios Pharmaceuticals Inc were $203.20 million.
increase of 72.3%
versus 2019, when the company's sales were $117.91 million.
This was the third consecutive year of growth at Agios Pharmaceuticals Inc.